These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37256266)

  • 21. Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model.
    Ma JH; Lee E; Yoon SH; Min H; Oh JH; Hwang I; Sung Y; Ryu JH; Bok J; Yu JW
    EBioMedicine; 2022 Aug; 82():104184. PubMed ID: 35870427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-frequency mosaicism in cryopyrin-associated periodic fever syndrome: mosaicism in systemic autoinflammatory diseases.
    Nishikomori R; Izawa K; Kambe N; Ohara O; Yasumi T
    Int Immunol; 2019 Sep; 31(10):649-655. PubMed ID: 31185077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.
    Carta S; Penco F; Lavieri R; Martini A; Dinarello CA; Gattorno M; Rubartelli A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2835-40. PubMed ID: 25730877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRP3.
    Verma D; Eriksson P; Sahdo B; Persson A; Ejdebäck M; Särndahl E; Söderkvist P
    Arthritis Rheum; 2010 Jul; 62(7):2138-43. PubMed ID: 20506209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC.
    Sušjan P; Lainšček D; Strmšek Ž; Hodnik V; Anderluh G; Hafner-Bratkovič I
    FASEB J; 2020 Aug; 34(8):11068-11086. PubMed ID: 32648626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies.
    McGeough MD; Wree A; Inzaugarat ME; Haimovich A; Johnson CD; Peña CA; Goldbach-Mansky R; Broderick L; Feldstein AE; Hoffman HM
    J Clin Invest; 2017 Dec; 127(12):4488-4497. PubMed ID: 29130929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HSP90β controls NLRP3 autoactivation.
    Spel L; Hou C; Theodoropoulou K; Zaffalon L; Wang Z; Bertoni A; Volpi S; Hofer M; Gattorno M; Martinon F
    Sci Adv; 2024 Mar; 10(9):eadj6289. PubMed ID: 38416826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CAPS and NLRP3.
    Booshehri LM; Hoffman HM
    J Clin Immunol; 2019 Apr; 39(3):277-286. PubMed ID: 31077002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Knock-In Mouse Model of Cryopyrin-Associated Periodic Syndromes.
    Bertoni A; Prigione I; Chiesa S; Ceccherini I; Gattorno M; Rubartelli A
    Methods Mol Biol; 2023; 2696():281-297. PubMed ID: 37578730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity.
    Putnam CD; Broderick L; Hoffman HM
    Immunol Rev; 2024 Mar; 322(1):259-282. PubMed ID: 38146057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants.
    Rieber N; Gavrilov A; Hofer L; Singh A; Öz H; Endres T; Schäfer I; Handgretinger R; Hartl D; Kuemmerle-Deschner J
    Clin Immunol; 2015 Mar; 157(1):56-64. PubMed ID: 25596455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes.
    Banoth B; Sutterwala FS
    J Clin Invest; 2017 Dec; 127(12):4235-4237. PubMed ID: 29130931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Chen Y; Chen X; Liang S; Ou Y; Lin G; Hua L; Wu X; Zhou Y; Liu Z; Cai H; Yang Z; Hu W; Sun P
    Chem Biol Interact; 2022 Sep; 365():110122. PubMed ID: 36002070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro.
    Braatz C; Komes MP; Ravichandran KA; de Fragas MG; Griep A; Schwartz S; McManus RM; Heneka MT
    J Neurochem; 2024 Oct; 168(10):3467-3481. PubMed ID: 36799439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Prevalence of
    Theodoropoulou K; Wittkowski H; Busso N; Von Scheven-Gête A; Moix I; Vanoni F; Hengten V; Horneff G; Haas JP; Fischer N; Palm-Beden K; Berendes R; Heubner G; Jansson A; Lainka E; Leimgruber A; Morris M; Foell D; Hofer M
    Front Immunol; 2020; 11():877. PubMed ID: 32477355
    [No Abstract]   [Full Text] [Related]  

  • 37. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.
    He Y; Franchi L; Núñez G
    J Immunol; 2013 Jan; 190(1):334-9. PubMed ID: 23225887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome.
    Theodoropoulou K; Spel L; Zaffalon L; Delacrétaz M; Hofer M; Martinon F
    J Allergy Clin Immunol; 2023 Jan; 151(1):222-232.e9. PubMed ID: 36075321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations.
    Mortimer L; Moreau F; MacDonald JA; Chadee K
    Nat Immunol; 2016 Oct; 17(10):1176-86. PubMed ID: 27548431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
    Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
    J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.